
Keywords: کوپرنیکس; AMD; age-related macular degeneration; ANCHOR; Anti-vascular endothelial growth factor (VEGF) Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization (CNV) in Age-related Macular Degeneration; BRAVO; Ranibizumab for the Treatment